A comparative analysis of mammography breast imaging reporting and data system score and fine needle aspiration cytology in the evaluation of palpable breast lump
DOI:
https://doi.org/10.18203/2320-6012.ijrms20192893Keywords:
BIRADS, Breast Lump, Fine-needle aspiration cytology, MammographyAbstract
Background: Breast lump is one of the commonest complaints with which patients present in breast clinics. As in most cases breast lump ultimately leads to a diagnosis of breast cancer, it is important for women with a breast lump to receive appropriate evaluation. So initial diagnostic approach such as utilization of rapid, inexpensive, presumptive and safe method is utmost important as such methods not only would benefit both patients and clinicians by prompting proper preoperative diagnosis and management but also further limits unnecessary testing and procedures. Aim and objectives of this study was to analyse the diagnostic accuracy of mammogram according to Breast Imaging Reporting and Data System (BI-RADS) score and fine-needle aspiration cytology (FNAC) in patients presented with benign and malignant breast lumps in authors centre.
Methods: During this retrospective study from January 2018 to December 2018, the subjects concerned included all the female patients, who were referred to the department of pathology for FNAC of their breast mass and had radiological reports (mammography) with BI-RADS score according to the latest guidelines. The sensitivity, specificity, accuracy, positive and negative predictive values of BI-RADS scores and FNAC in diagnosis of breast diseases was done on the basis of final diagnosis.
Results: In this study, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy was 88.57%, 82.46%,75.61%,92.16% and 84.78%, respectively for Mammography (BIRADS) score and 100% for all the parameters on FNAC.
Conclusions: According to authors above study findings concluded that FNAC could be considered an ideal initial diagnostic modality in all breast lumps recognized by means of imaging techniques. It is not only considered as safe, cost effective, rapid and presumptive diagnostic method but also further limits unnecessary testing and procedures.
References
Tiwari M. Role of fine needle aspiration cytology in diagnosis of breast lumps. Kathmandu Univ Med J.2007;5(2):215-7.
Pruthi S. Detection and evaluation of a palpable breast mass. Mayo Clin Proc. 2001;76(6):641-7;quiz 647-8.
Kachewar SS, Dongre SD. Role of triple test score in the evaluation of palpable breast lump. Indian J Med Paediatr Oncol. 2015;36(2):123-7.
Rahman MZ, Sikder AM, Nabi SR. Diagnosis of breast lump by fine needle aspiration cytology and mammography. Mymensingh Med J. 2011;20(4):658-64.
Bak M, Konyár E, Schneider F, Bidlek M, Szabó E, Nyári T, et al. Quality assurance of fine-needle aspiration cytology of the organized mammography screening] Orv Hetil. 2010; 151(32):1295-8.
Spak DA, Plaxco JS, Santiago L, Dryden MJ, Dogan BE. BI-RADS®fifth edition: A summary of changes. Diagn Interv Imaging. 2017;98(3):179-90.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer J Clin. 2018;68(6):394-424.
Singla D, Chaturvedi AK, Aggarwal A, Rao SA, Hazarika D, Mahawar V. Comparing the diagnostic efficacy of full field digital mammography with digital breast tomosynthesis using BIRADS score in a tertiary cancer care hospital. Indian J Radiol Imaging. 2018;28(1):115-22.
Garg S, Mohan H, Bal A, Attri AK, Kochhar S. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions. Diagn Cytopathol. 2007;35(11):681-9.
National Cancer Institute. SEER 1973-2001 public-use data. Accessed online October 14, 2004. Available at: http://seer.cancer.gov/publicdata/.
International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide [Internet]. 2012 [Accessed on June 2015]. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
Jaffary A, Mansuri F, Shani S, Shani S. Knowledge, attitudes and practices regarding breast cancer screening in women of various social strata. J Surg Pak. 2005;10:44-7.
Cusheiri A, Steele RJ, Mossa A. Essential surgical practice. 4th ed. Oxford: Butterworth Heinimann; 2002:72-73.
Acr.org. 2019. Available at: https://www.acr.org/-/media/ACR/Files/RADS/BI-RADS/BIRADS-Reference-Card.pdf.
Bhramaramba K, Padma S, Hemalatha S, Murthy NLN. A comparative study of FNAC breast lesions and BIRADS grading with a focus on grade 4 and grade 5 categories. Int Arch Integrative Med. 2017;4(9):156-63.
Engohan-Aloghe C, Hottat N, Cosaert J, Boutemy R, Fayt I, Noël JC. Evaluation of accuracy of fine needle aspiration cytology in BI-RADS3 category breast lesions: cytohistological correlation in 337 cases. Cytopathology. 2010;21(3):161-3.
Jatala S, Fitzgerald S, Tietze P, Ramakrishnan K, McCarthy LH, Wickersham E. What Are the Recommended Timing and Screening Modalities in Women at Higher Risk for Developing Breast Cancer? A Clin-IQ. J Patient Cent Res Rev. 2015;2(1):38-42.
Muttarak EM, Pojchamarnwiputh S, Chaiwun B. Breast cancer in women under 40 years: preoperative detection by mammography. Ann Acad Med Singapore. 2003;32(4):433-7.
Berg WA, Gutierrez L, Nessaiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiol. 2004;233(3):830-49.
Coveney EC, Geraghty JG, O'Laoide R, Hourihane JB, O'Higgins NJ. Reasons underlying negative mammography in patients with palpable breast cancer. Clin Radiol. 1994;49(2):123-5.
Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003;139(4):274-84.
Tiwari P, Ghosh S, Agrawal VK. Evaluation of breast lesions by digital mammography and ultrasound along with fine-needle aspiration cytology correlation. J Can Res Ther. 2018;14(5):1071-4.
Engvad B, Laenkholm AV, Schwartz W, Bak M. Fine needle aspiration cytology of mammography screening. Ugeskr Laeger. 2009;171(34):2379-82.
Bukhari MH, Arshad M, Jamal S, Niazi S, Bashir S, Bakhshi IM. Use of fine-needle aspiration in the evaluation of breast lumps. Pathol Res Int. 2011;2011:689521.
Panjvani SI, Parikh BJ, Parikh SB, Chaudhari BR, Patel KK, Gupta GS, et al. Utility of fine needle aspiration cytology in the evaluation of breast lesions. J Clin Diagn Res. 2013;7(12):2777-9.
Sankaye SB, Dongre SD. Cytological study of palpable breast lumps presenting in an Indian rural setup. Indian J Med Paediatr Oncol. 2014;35(2):159-64.
Choi YD, Choi YH, Lee JH, Nam JH, Juhng SW, Choi C. Analysis of fine needle aspiration cytology of the breast: A review of 1,297 cases and correlation with histologic diagnoses. Acta Cytol. 2004;48(6):801-6.
